Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last ¥2,366 JPY
Change Today +40.00 / 1.72%
Volume 938.1K
2413 On Other Exchanges
Symbol
Exchange
Tokyo
OTC US
As of 2:00 AM 05/25/15 All times are local (Market data is delayed by at least 15 minutes).

m3 inc (2413) Snapshot

Open
¥2,357
Previous Close
¥2,326
Day High
¥2,372
Day Low
¥2,335
52 Week High
03/3/15 - ¥2,738
52 Week Low
05/26/14 - ¥1,487
Market Cap
765.4B
Average Volume 10 Days
1.4M
EPS TTM
¥30.18
Shares Outstanding
323.5M
EX-Date
03/29/16
P/E TM
78.4x
Dividend
¥8.00
Dividend Yield
0.34%
Current Stock Chart for M3 INC (2413)

Related News

No related news articles were found.

m3 inc (2413) Related Businessweek News

No Related Businessweek News Found

m3 inc (2413) Details

M3, Inc. provides medical-related services primarily to physicians and other healthcare professionals through Internet. It operates m3.com, a members-only Web site for providing information to the healthcare professionals; and MR-kun that delivers the medical and drug information online through m3.com. The company also offers MDLinx, which provides the review of medical articles in English for physicians in the United States; and MEDI:GATE that provides medical news and content, and features online discussion boards where doctors can exchange opinions and communicate with one another in South Korea. In addition, its services for pharmaceutical and other medical-related companies include large-scale clinical trial services, clinical trial support services, market research services, doctor and pharmacist recruiting support services, and marketing support services for medical solution providers. Further, the company provides services for general public that comprise the operation of AskDoctors, a Q&A site to consult doctors through the Internet; AskMoon Women’s Medicine, a site that helps women manage their health and beauty; AskMind*Heart Diary, a site for mental health management based on the recent psychology; and iTicket Plus, a reservation system for clinics through mobile phones and the Internet. The company was formerly known as So-netM3, Inc. and changed its name to M3, Inc. in January 2010. M3, Inc. was founded in 2000 and is headquartered in Tokyo, Japan.

Founded in 2000

m3 inc (2413) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

m3 inc (2413) Key Developments

M3, Inc. Announces Consolidated and Unconsolidated Earnings Results for the Year Ended March 31, 2015; Provides Earnings Guidance for the Second Quarter of 2016 and Full Year Ending March 31, 2016

M3, Inc. announced consolidated and unconsolidated earnings results for the year ended March 31, 2015. For the year, on the consolidated basis, the company’s net sales were JPY 51,346 million against JPY 36,759 million a year ago. Operating profit was JPY 16,061 million against JPY 13,738 million a year ago. Pre-tax profit was JPY 16,174 million against JPY 13,927 million a year ago. Net profit was JPY 10,428 million against JPY 8,878 million a year ago. Profit attributable to owners of the parent was JPY 9,759 million against JPY 8,415 million a year ago. Diluted earnings per share were JPY 30.13 against JPY 26.29 a year ago. Cash flows from operating activities were JPY 9,316 million against JPY 8,896 million a year ago. The major component of inflow was pre-tax profit of 16,174 million yen, and the major component of outflow was corporate income tax of 5,354 million yen. For the fiscal year ending March 31, 2016, on consolidated basis, the company expects net sales of JPY 63,000 million, operating profit of JPY 19,000 million, pre-tax profit of JPY 19,000 million, net profit of JPY 12,000 million, earnings attributable to the owners of the parent of JPY 11,300 million and basic earnings per share of JPY 34.95. For the second quarter of 2016, on consolidated basis, the company expects net sales of JPY 29,000 million, operating profit of JPY 8,500 million, pre-tax profit of JPY 8,500 million, net profit of JPY 5,200 million, earnings attributable to the owners of the parent of JPY 4,800 million and basic earnings per share of JPY 14.85. For the year, on the unconsolidated basis, the company’s net sales were JPY 17,727 million against JPY 16,254 million a year ago. Operating profit was JPY 10,085 million against JPY 9,129 million a year ago. Ordinary profit was JPY 11,497 million against JPY 9,803 million a year ago. Net profit was JPY 7,481 million against JPY 5,979 million a year ago. Diluted earnings per share were JPY 23.10 against JPY 18.68 a year ago. Net asset per share was JPY 118.22 as on March 31, 2015.

M3, Inc. to Report Fiscal Year 2015 Results on Apr 24, 2015

M3, Inc. announced that they will report fiscal year 2015 results on Apr 24, 2015

M3, Inc., 2015 Earnings Call, Apr 24, 2015

M3, Inc., 2015 Earnings Call, Apr 24, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
2413:JP ¥2,366.00 JPY +40.00

2413 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Don Quijote Holdings Co Ltd ¥9,820 JPY +100.00
View Industry Companies
 

Industry Analysis

2413

Industry Average

Valuation 2413 Industry Range
Price/Earnings 76.3x
Price/Sales 14.5x
Price/Book 16.4x
Price/Cash Flow 76.2x
TEV/Sales 14.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact M3 INC, please visit corporate.m3.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.